Jim O’Connell co-founded Envara Health and has built an extraordinary executive team from healthcare, nutrition, and biotech to orchestrate the successful introduction of EncalaTM. He has over 20 years of operational, financial, and entrepreneurial experience in the life sciences. At Safeguard Scientifics, a venture capital firm, Jim led investments in innovative healthcare companies. He was in the Business Development group at Becton Dickinson, a F500 medical technology firm, and prior held operating roles at two successful startups: Chemdex Corp. (IPO in 1999, acquired in 2002) and Biosite Diagnostics (IPO in 1997, acquired in 2007).